News
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...
Dr William Li, whose book Eat to Beat Your Diet is a New York Times bestseller, says the most dangerous type of fat is ...
Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results